MA41620A - Composition pharmaceutique comprenant de la siméthicone et de l'otilonium - Google Patents

Composition pharmaceutique comprenant de la siméthicone et de l'otilonium

Info

Publication number
MA41620A
MA41620A MA041620A MA41620A MA41620A MA 41620 A MA41620 A MA 41620A MA 041620 A MA041620 A MA 041620A MA 41620 A MA41620 A MA 41620A MA 41620 A MA41620 A MA 41620A
Authority
MA
Morocco
Prior art keywords
otilonium
simethicone
pharmaceutical composition
composition consisting
pharmaceutical
Prior art date
Application number
MA041620A
Other languages
English (en)
Inventor
Kadriye Akdag
Gokhan Bayrak
Udaya Kumar Dude
Ferhad Farsi
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret A S filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret A S
Publication of MA41620A publication Critical patent/MA41620A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA041620A 2015-05-14 2016-05-13 Composition pharmaceutique comprenant de la siméthicone et de l'otilonium MA41620A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201505845 2015-05-14

Publications (1)

Publication Number Publication Date
MA41620A true MA41620A (fr) 2018-01-09

Family

ID=56014760

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041620A MA41620A (fr) 2015-05-14 2016-05-13 Composition pharmaceutique comprenant de la siméthicone et de l'otilonium

Country Status (2)

Country Link
EP (1) EP3173076B1 (fr)
MA (1) MA41620A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3294269A1 (fr) * 2015-06-12 2018-03-21 Santa Farma Ilaç Sanayi A.S. Composition pharmaceutique orale comprenant du bromure d'otilonium et de la siméthicone présentant une certaine densité en vrac et des caractéristiques de dissolution améliorées

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578423B1 (fr) 1985-03-06 1988-12-30 Grimberg Georges Composition pharmaceutique a base de gomme de guar pour la protection de la muqueuse oeso-gastro-duodenale
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5073384A (en) 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
IN171919B (fr) 1989-11-01 1993-02-06 Mcneil Ppc Inc
GR1002332B (el) 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
FR2705966B1 (fr) 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7341742B2 (en) 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
WO2008056200A1 (fr) 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Compositions pharmaceutiques orales de siméthicone
WO2010092436A1 (fr) * 2009-02-12 2010-08-19 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Combinaisons pharmaceutiques de siméthicone et d'otilonium
WO2013095111A1 (fr) 2011-12-14 2013-06-27 Disphar International B.V. Formulation de siméthicone
CN104523717A (zh) * 2015-01-06 2015-04-22 西南大学 西甲硅油奥替溴铵咀嚼片及其制备方法
EP3294269A1 (fr) * 2015-06-12 2018-03-21 Santa Farma Ilaç Sanayi A.S. Composition pharmaceutique orale comprenant du bromure d'otilonium et de la siméthicone présentant une certaine densité en vrac et des caractéristiques de dissolution améliorées

Also Published As

Publication number Publication date
EP3173076B1 (fr) 2021-07-14
EP3173076A1 (fr) 2017-05-31

Similar Documents

Publication Publication Date Title
MA43709A (fr) Composition pharmaceutique comprenant de l'empagliflozine et ses utilisations
MA46820A (fr) Composition pharmaceutique comprenant des constructions d'anticorps bi-spécifiques
MA50753A (fr) Compositions d'acide nucléique-polypeptide et utilisations de celles-ci
FR21C1057I2 (fr) Composition pharmaceutique stable à dose fixe comprenant de la mométasone et de l'olopatadine
DK3676316T3 (da) Flydende sammensætning omfattende biologiske enheder og anvendelser deraf
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
MA49043A (fr) Formulation stable d'anticorps
MA46481A (fr) Compositions d'oligonucléotides et méthodes associées
MA49726A (fr) Formulation d'anticorps anti-cgrp
MA43308A (fr) Molécules d'anticorps se liant à april et leurs utilisations
MA46466A (fr) Formulations pharmaceutiques de protéines à viscosité réduite
MA47688A (fr) Compositions utiles dans le traitement de l'amyotrophie spinale
MA51747A (fr) Formulation d'anticorps pharmaceutique à ph faible
MA46334A (fr) Composition pharmaceutique liquide
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
MA43361A (fr) Composition pour le soin et la protection de cultures
DK3532029T3 (da) Flydende farmaceutisk sammensætning
MA49116A (fr) Compositions pharmaceutiques contenant de l'insuline
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA47516A (fr) Composition pharmaceutique
FR3022462B1 (fr) Composition orale d'anticorps anti-tnfalpha
MA40781A (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
MA43705A (fr) Formulation pharmaceutique
MA53021A (fr) Composition de diacide oligosaccharidique d'alginate
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen